Skip to main content
BELLUSCURA PLC logo

BELLUSCURA PLC — Investor Relations & Filings

Ticker · BELL ISIN · GB00BD3B8Z11 LEI · 213800BRJQZE56XBPW94 IL Manufacturing
Filings indexed 240 across all filing types
Latest filing 2022-11-10 Regulatory Filings
Country GB United Kingdom
Listing IL BELL

About BELLUSCURA PLC

https://belluscura.com/

Belluscura PLC is a medical device company specializing in the development and commercialization of advanced oxygen enrichment technologies. The company's primary focus is on manufacturing lightweight, portable oxygen concentrators (POCs) designed to improve the quality of life for individuals requiring supplemental oxygen therapy. Its product portfolio is headlined by the FDA-cleared X-PLOR® and the DISCOV-R™ models. These devices utilize proprietary, patented technologies such as ModulAir™ and an Airgonomical™ design to deliver high oxygen output in a compact form factor, offering an alternative to traditional, cumbersome oxygen tanks and promoting user mobility and independence.

Recent filings

Filing Released Lang Actions
Belluscura receives certification to ISO standard
Regulatory Filings Classification · 100% confidence The document is identified by the RNS Number header and the explicit mention of 'RNS Number : 9055F' and 'THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION'. The content announces a significant operational achievement (ISO certification) which enables global distribution, rather than releasing periodic financial results (ER/IR) or detailed management commentary (MDA). Since it is a formal announcement disseminated via the Regulatory Information Service (RNS) that doesn't fit into a more specific category like Director's Dealing (DIRS) or Dividend Notice (DIV), it falls best under the general Regulatory Filings category, which serves as the fallback for miscellaneous regulatory announcements.
2022-11-10 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is titled 'Notification of Major Holding' and explicitly states that the company received notification that Tekcapital Plc has reduced its holding from 13.932% to 12.3062% of the total voting rights. This directly relates to changes in significant share ownership levels, crossing thresholds, which aligns perfectly with the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2022-10-31 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document explicitly states it is an RNS Number announcement from Belluscura PLC, dated October 31, 2022. The content details the acquisition of shares by a Director/PDMR (David Poutney) and his spouse. This directly matches the definition of 'Director's Dealing' (insider trades). Although it is distributed via RNS, the specific content dictates the classification should be DIRS, as DIRS is a more specific category than the general RNS fallback. The document structure (RNS header, PDMR notification tables) confirms this is a regulatory filing reporting insider transactions.
2022-10-31 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is clearly identified by the 'RNS Number' header and contains language typical of regulatory dissemination services ('This information is provided by RNS, the news service of the London Stock Exchange'). The content specifically details 'Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs")' involving the CEO, Robert Rauker, including the sale of shares to cover exercise costs and taxes. This directly matches the definition of Director's Dealing (insider trades). Therefore, the appropriate code is DIRS.
2022-10-31 English
Belluscura wins two HME Business Awards
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' header and contains information typical of a press release distributed via the Regulatory News Service (RNS). The content announces product awards won by Belluscura plc, which is corporate/marketing news rather than a mandatory regulatory filing like a 10-K, earnings release, or capital change. The footer explicitly states: 'Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain.' This strongly indicates a non-regulatory announcement. Since it is a general corporate announcement that doesn't fit specific categories like DIV, MANG, or ER, the most appropriate fallback category is Regulatory Filings (RNS), as it is distributed through the RNS system but explicitly marked as non-regulatory news.
2022-10-24 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields related to voting rights, share percentages, and notification dates, which are characteristic of regulatory filings concerning significant changes in share ownership. The RNS Number (4846A) and the mention of the FCA (Financial Conduct Authority) confirm its regulatory nature. This specific form type directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers changes in significant share ownership levels crossing thresholds.
2022-09-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.